Nepal vs Senegal: Average cost of drugs for extensively drug-resistant tuberculosis

Nepal

2,853 constant 2022 US$

in 2024

Senegal

3,428 constant 2022 US$

in 2024

Nepal rank

21st

Senegal rank

20th

Average cost of drugs for extensively drug-resistant tuberculosis over time

Senegal currently reports 3,428 constant 2022 US$ against 2,853 constant 2022 US$ in Nepal, a difference of 575 constant 2022 US$.

That makes Senegal's figure about 1.2 times Nepal's.

The two have swapped places 2 times across 5 shared years of data; in 2018 it was Senegal ahead.

Nepal ranks 21st and Senegal ranks 20th of 56 countries.

Indicator: Average cost of drugs for extensively drug-resistant tuberculosis
Unit: constant 2022 US$
Source: WHO (2025) – with minor processing by Our World in Data
Licence: CC BY 4.0 (Our World in Data)
Coverage: 56 places, 394 data points, 2017–2024
Last refreshed: 07 August 2026

Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.